Clarity Pharmaceuticals Ltd (ASX:CU6)
Australia · Delayed Price · Currency is AUD 3.190
+0.140 (4.59%)
Apr 8, 2026, 12:59 PM AEST
Clarity Pharmaceuticals Market Cap
Clarity Pharmaceuticals has a market cap or net worth of 1.14 billion as of April 7, 2026. Its market cap has increased by 40.20% in one year.
Market Cap
1.14B
Enterprise Value
909.14M
Revenue
10.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.19
Market Cap Chart
Since August 25, 2021, Clarity Pharmaceuticals's market cap has increased from 384.20M to 1.14B, an increase of 195.52%. That is a compound annual growth rate of 26.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 1.14B | -9.71% |
| Dec 31, 2025 | 1.26B | -6.00% |
| Dec 31, 2024 | 1.34B | 168.49% |
| Dec 29, 2023 | 498.26M | 93.82% |
| Dec 30, 2022 | 257.07M | 35.63% |
| Dec 31, 2021 | 189.54M | -50.67% |
| Aug 25, 2021 | 384.20M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 4.39B |
| Mesoblast | 2.75B |
| Neuren Pharmaceuticals | 1.52B |
| PYC Therapeutics | 1.10B |
| Opthea | 738.77M |
| Racura Oncology | 479.29M |
| Clinuvel Pharmaceuticals | 452.81M |
| Tetratherix | 220.32M |